Pricing

OPTIMER PHARMACEUTICALS INC

0 followers ·
JERSEY CITY NJ
Optimer Pharmaceuticals is based out of Jersey City. Optimer Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing anti-infective products primarily to treat gastrointestinal infections and related diseases. Its product candidates include Difimicin (OPT-80), which is in Phase 3 registration trial for the treatment of Clostridium Difficile-associated diarrhea (CDAD), and for the prevention of CDAD; and prevention of nosocomial vancomycin-resistant enterococci bloodstream infections, and methicillin-resistant staphylococci prophylaxis. The company is also developing Prulifloxacin, which is under Phase 3 trial for the treatment of infectious diarrhea, including traveler's diarrhea; OPT-88, a therapy for osteoarthritis; OPT-822/OPT-821, a cancer immunotherapy for the treatment of metastatic breast cancer; and OPT-1068 and OPT-1273 antibiotics for the treatment of upper and lower respiratory tract infections. It has a collaboration agreement with Par Pharmaceutical, Inc. for the clinical development and commercialization of Difimicin; as well as a collaborative research and development, and license agreement with Cempra Pharmaceuticals, Inc. to discover, develop, and commercialize drugs based on macrolide and ketolide compounds.Whalewisdom has at least 66 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.

Contact Info

Contact information is taken directly from publicly disclosed SEC filings.

OPTIMER PHARMACEUTICALS INC
101 HUDSON STREET
JERSEY CITY NJ    07302

Business Phone: (201) 333-8819
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Filing Date
4 2008-06-13
4 2008-06-13
4 2008-03-12
4 2008-01-24
4 2008-01-04
4 2008-01-04
4 2008-01-04
4 2008-01-04
4 2008-01-04
4 2008-01-04